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Expanding Magnetic Resonance Imaging Access for Patients with Cardiovascular Implantable 
Electronic Devices 
Abstract 
Problem. Patients with non-conditional cardiovascular implantable electronic devices (CIEDs), 
which lack magnetic resonance imaging (MRI) components, are unable to undergo MRI.    
Context.  The Heart Rhythm Society guidelines for patient device management and Centers for 
Medicare and Medicaid Services requirements for persons with specific expertise in implanted 
permanent devices to manage CIEDs during MRI spurred policy, procedure and staffing 
changes. 
Interventions. The evidence-based change-of-practice project comprised of workflow 
development, policy and procedure changes, implementation of required staffing support to 
manage the CIED during an MRI. 
Measures: The outcome measure was to improve access to MRI for patients with CIEDs, 
measured through data extracted from the Clinical Business Analytics reporting tool. Three 
process measures determined the change in numbers of patients presenting for, excluded from, or 
receiving MRIs as a consequence of the intervention.  
Results.  CIED MRI workflows and the revised policy and procedure were finalized.  Since 
implementation of extended hours of CIED support on October 7, 2019, the arrhythmia NP has 
supervised 18 MRIs after 5 pm.   
Conclusions. The project expanded MRI access and CIED management support for all patients, 
ensuring high-quality care aligned with institutional standards and government regulations.  
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Section II. Introduction  
Problem Description 
The healthcare organization selected for this project is a large academic medical center 
(AMC).  The stakeholders for this project include the arrhythmia, neurology, and radiology 
leadership teams, medical directors, arrhythmia nurse practitioners (NPs), neurology, and 
radiology staff.  The Doctorate in Nursing Practice (DNP) student is a member of the 
Cardiovascular Health (CVH) Service Line leadership team and is working with the stakeholders 
and department team members on this improvement project.  The AMC was slow to adopt the 
2017 Heart Rhythm Society (HRS) non-conditional device management guidelines.  The AMC’s 
CIED MRI policy and procedure addressed only the oversight of conditional CIEDs, therefore 
limiting the arrhythmia team’s scope of service.  The arrhythmia team was not assisting in the 
supervision of non-conditional CIEDs during magnetic resonance imaging (MRI).   The AMC’s 
arrhythmia physicians needed more evidence-based data demonstrating the safety of MRIs for 
patients with non-conditional CIEDs in order to agree to provide MRIs for these patients.  The 
current arrhythmia staffing model could not support adding MRI services for patients even if the 
physicians agreed to do so.   
In January 2018, the Centers for Medicare and Medicaid Services (CMS) proposed 
changes in the management and supervision of patients with CIEDs who require MRIs.  CMS 
requires that a qualified physician, NP, or physician assistant (PA) with expertise in implanted 
permanent pacemakers (PM), implantable cardioverter defibrillator (ICD), cardiac 
resynchronization therapy pacemakers (CRT-P), or cardiac resynchronization therapy 
defibrillators (CRT-D) must directly supervise patients with CIEDs during an MRI.  Despite 
HRS’s recent consensus statement and CMS’s staffing requirements supporting the supervision 
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of non-conditional CIEDs, the AMC had not yet taken steps to provide device management for 
patients with non-conditional CIEDs.  
In 2017, the neurology team conducted a retrospective chart review of patients 18 years 
or older who had received an inpatient neurology consultation for conditions warranting a brain 
MRI and who had a pre-existing non-conditional CIED.  The neurology team concluded that on 
average 2.5 patients per month presented with an acute neurological condition and did not 
receive an MRI because of their non-conditional CIED.  These patients were referred to other 
testing methods or sent to another facility to complete the MRI.  The number of patients being 
deferred an MRI was reported to the arrhythmia and radiology leadership teams, where critical 
patient safety concerns were raised.    
The AMC did not have standardized CIED MRI safety protocols and workflows in 
place.  The DNP project included the development of CIED management workflows for MR 
non-conditional CIEDs, updating the device management policy and procedure, as well as 
defining and implementing safe staffing support to deliver CIED management during an 
MRI.  After months of collaboration, the systematic workflows created by the arrhythmia team to 
support the management of non-conditional and urgent requests were approved by the 
arrhythmia, neurology, and radiology teams.  Implementation of these workflows was dependent 
on the development of an arrhythmia team-staffing plan to facilitate and provide appropriate 
clinical support for these patients. The arrhythmia, neurology, and radiology teams worked 
collaboratively to assess and develop a staffing model to address the Centers for Medicare and 
Medicaid Services (CMS) requirements.  
The importance of this improvement project is the promotion of safety protocols and 
adherence to CMS guidelines.  Nurses play a critical role in ensuring safe patient practice, 
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understanding care processes and facilitating efficient workflows.  This project was supported by 
the AMC and deemed one of significant scope (see Appendix A).  The DNP project included the 
development of CIED management workflows for MR non-conditional CIEDs, updating the 
device management policy and procedure, as well as defining and implementing safe staffing 
support to deliver CIED management during an MRI. 
Available Knowledge 
PICOT question.  For patients who need an MRI and have a CIED, how does the 
application of nationally recommended staffing standards compare to the current device 
management support improve patient access and throughput by October 7, 2019?  
Literature review.  The PICOT question guided a systematic search and a 
comprehensive review of the literature using the following search terms: magnetic resonance 
imaging, cardiac implantable electronic devices, MRI, MRI safety, MRI adverse effects, CIED, 
CIED interference, pacemaker, and implantable cardioverter defibrillator.  The following 
databases were accessed to search for relevant literature: Cochrane, CINAHL, PubMed, 
Evidence-Based Journals, Scopus, Medscape, Heart Rhythm Society, and American Heart 
Association.  The search yielded 30 articles from which 12 were selected. Articles were selected 
if they addressed CIEDs, MRIs, safety, safety concerns, were written in the English language, 
and were published between 2011 and 2018.  Inclusion criteria were: MRI safety protocol, MRI 
magnetic strength, and conditional and non-conditional CIEDs.  Articles were excluded if they 
were focused only on a product from one manufacturer.   
Articles were critically appraised with the Johns Hopkins Nursing Evidence-Based 
Practice Non-Research and Research Evidence Appraisal Tools (Dang & Dearholt, 2018). These 
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tools provided a concise appraisal of the level and quality of the evidence.  Articles were chosen 
based on the strength and quality of research evidence.   
Two of the nine studies were prospective, single non-randomized studies.  The study by 
Nazarian et al. (2017) and Bailey et al. (2016) reviewed conditional and non-conditional CIED 
interrogation results before and after the MRI with the utilization of a standardized device 
management protocol.  Device interrogation with lead comparison was performed at enrollment, 
pre- and post-MRI scan, one-month post-MRI, and three-month post-MRI.  Both studies 
compared the effects of thoracic and non-thoracic MRI on CIEDs.  The results of these studies 
demonstrated no long-term clinically significant adverse events were associated with the MRIs.  
Limitations included small sample sizes and low number of cardiac MRIs.  Based on the Johns 
Hopkins Research Evidence Appraisal Tool, both studies were rated II-A. 
Two prospective, multicenter cohort studies by Jung, Sebastian, and Zvereva (2015) and 
Russo et al. (2017) analyzed CIED interrogation results before and after an MRI with the 
utilization of a standardized protocol.  All studies were performed in a 1.5 tesla (T) MRI scanner.  
The study by Jung, Sebastian, and Zvereva (2015) identified the prospective adverse event rate 
and parameter changes in non-MRI CIEDs using a device registry and determined that the MRI 
risk was low.   Russo et al. (2017) analyzed PM and ICD data and confirmed the safety of non-
MRI conditional CIEDs who underwent clinically indicated non-thoracic MRI at 1.5T.  Device 
or lead failure did not occur in both studies at 1.5T but was not predictive of findings with testing 
at higher magnetic strength, up to 3T. Both studies were rated III A/B using the Johns Hopkins 
Research Evidence Appraisal Tool. 
 In the studies chosen, the one retrospective cohort study by Dandamudi et al. (2016) 
reviewed the device assessment reports in the electronic medical records of patients with CIEDs 
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before and after an MRI performed according to a CIED safety protocol.  When a comprehensive 
CIED MRI protocol was followed, the risk of performing 1.5T MRI with the device in the 
isocenter, including PM dependent patients was low.  There were no significant changes in atrial 
and ventricular sensing impedance, and threshold measurements.  There were no episodes of 
device mode changes, arrhythmias, therapies delivered, electrical reset, or battery depletion.  
This study is appraised as III A/B per the Johns Hopkins Research Evidence Appraisal Tool. 
One prospective cohort study by Yadava et al. (2017) reviewed 277 patients who had 
undergone 293 scans.  The CIEDs included 170 PMs and 71 ICDs.  Devices were interrogated 
before and after the MRI with the use of a standardized protocol.  The study demonstrated no 
changes in device settings during an MRI.  Long-term follow-up device assessment confirmed no 
adverse effects from 1.5T MRI.  According to the Johns Hopkins Research Evidence Appraisal 
Tool, both studies were rated III A/B. 
Two randomized control trials (RCT) by Shenthar et al. (2015) and Wilkoff et al. (2011) 
analyzed CIEDs before, during, and after the MRI with the use of an MRI scan protocol.  The 
study by Shenthar et al. (2015), evaluated MRI safety without positioning restrictions in patients 
with MR conditional PM with non-MR conditional leads.  Two hundred sixty-six patients were 
sampled with a two to one ratio to the MRI group or control group.  There were no related 
complications immediately post or at one-month post-MRI.  The second RCT by Wilkoff et al. 
(2011) evaluated PM performance and pacing capture threshold nine to twelve weeks prior to the 
MRI, during the MRI, and immediately after the MRI.  Four hundred sixty-four patients were 
randomized to undergo an MRI scan between nine to twelve weeks of post-CIED 
implantation.  Patients were monitored for arrhythmias, symptoms, and PM system function 
during fourteen non-clinically indicated brain and lumbar MRI sequences.  It was found that no 
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MRI related complications occurred during or after the MRI.  Based on the Johns Hopkins 
Research Evidence Appraisal Tool, both studies were rated I-A. 
One meta-analysis and systematic review performed by Shah et al. (2018) utilized a 
random-effects model for meta-analysis of continuous variables including device lead parameters 
such as capture threshold, sensing, and impedance; high-voltage ICD lead impedance, and 
battery voltage change.  Safety outcomes were evaluated with descriptive analysis.  Indexed 
articles from PubMed were queried between the years 1990-2017.  The search yielded one 
thousand three hundred twenty-four records to review.  Seventy studies were included for the 
systematic review, and five thousand ninety-nine patients were identified.  The brain or cervical 
spine was imaged the most and thoracic imaging was completed in seven hundred seventy-three 
patients.  The meta-analysis cohort included thirty-one studies.  This analysis summarized the 
safety profile of five thousand nine-hundred eight MRI studies in five thousand ninety-nine 
patients with non-MRI conditional CIEDs in a span of twenty-five years.  There were no 
reported deaths and three total lead failures.  There were no relevant changes in lead, battery, or 
pulse generator performance.  The observed changes were small, and inter-study variance was 
low.  The findings suggested the need for ongoing monitoring.  Per the Johns Hopkins Research 
Evidence Appraisal Tool, the study was rated III A/B. 
Viera, Lazoura, Nicol, Rubens, and Padley (2013) analyzed data from a multicenter 
device registry.  Devices were interrogated before and after an MRI with the use of a 
standardized protocol.  The technical report confirmed the need for utilization of a 
comprehensive safety protocol and substantiated the development of new generation MRI 
conditional CIEDs.  According to the Johns Hopkins Research Evidence Appraisal Tool, the 
study was rated III A/B. 
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A clinical review by Nordbeck, Ertl, and Ritter (2015) provided a better understanding of 
the structures responsible for life-threatening complications as well as technical advances 
supporting the safety of MRIs for CIEDs.  Clinical trials were reviewed over the last twenty 
years, including fourteen PM and thirteen ICD studies.  The studies assessed the outcome in 1.5T 
scanners and reported there were no adverse events. This was the only abstract found in the 
literature review that demonstrated CIED safety during an MRI with appropriate monitoring and 
application of a safety protocol.  It attempted to offer an up-to-date and clinically useful 
summary for practicing cardiologists.  Based on the Johns Hopkins Research Evidence Appraisal 
Tool, the study was rated III A/B. 
In summary, the literature between 2011 and 2018 showed non-conditional CIEDs 
undergoing 1.5T MRI had been evaluated pre, intra, and post MRI and demonstrated minimal to 
no MRI-related complications or adverse effects.  A CIED safety protocol was utilized in all the 
studies.  Many of the studies reported CIED reprogramming before and after the MRI.   The 
clinical review supported the utilization of appropriate monitoring and a safety protocol for 
CIEDs during an MRI. 
Findings from all the studies support the safety of an MRI for patients with conditional as 
well as non-conditional CIEDs at the magnetic strength of 1.5T and validated the 2017 HRS 
consensus statement demonstrated in the evaluation table (see Appendix B).  MRIs were 
performed with appropriate monitoring and the utilization of a safety protocol. Based on the 
literature, more research is needed to evaluate the safety of MRIs at higher magnetic strength, 
greater than 1.5T.  Studies were limited due to the utilization of 1.5T magnetic strength.  Several 
studies had small sample sizes.   The studies by Yadava et al. (2017) and Nazarian et al. (2017) 
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could not accurately obtain follow-up device data because patients were referred by outside 
physicians or patients were lost to follow-up. 
Rationale 
Conceptual framework.  The conceptual framework for this project was a combination 
of complexity theory and change theory.  Complexity theory analyzes complex systems, strives 
to understand their structure and purpose, and recognizes the importance of inter-relationships 
and context (Litaker, Tomolo, Liberatore, Stange, & Aron, 2006).  Complexity theory relates to 
organizational theory through understanding how organizations adapt to their environment and 
their coping mechanisms.  In quality improvement, complexity theory thinking is utilized in 
understanding how individuals and organizations adapt to an uncertain environment while they 
respond to change-initiating events.  Complexity theory asserts that people and organizations are 
non-linear and complex adaptive systems (Grossman & Valiga, 2013).  This framework was 
suitable for the implementation of a comprehensive CIED MRI workflow algorithm and staffing 
model.  The AMC can be treated as a complex adaptive system exhibiting emergence, 
complexity, chaos, self-organization, and interdependence.   
Kurt Lewin developed the change theory of nursing and defined behavior as a dynamic 
balance of forces working in opposite directions (Batras, Duff, & Smith, 2014).   Lewin’s change 
theory allowed the evaluation of group behavior and involved understanding its complexity and 
influence on observed behaviors (Batras, Duff, & Smith, 2014).  Health care providers 
facilitating change integrate this theory into the development of interventions.  Lewin designed a 
three-step model for change: unfreezing, moving (change), and refreezing, Unfreezing involves 
creating uneasiness with the status quo, represented in the neurology study that concluded 2.5 
patients per month did not receive an MRI because of their non-conditional CIED.  It is also 
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demonstrated in the development of the NP staffing model based on CMS guidelines.  Moving is 
the act of change, the implementation of the proposed workflows and NP staffing model.  
Refreezing is when change becomes the norm, demonstrated in the supervision and management 
for all patients with CIEDs during an MRI. 
Specific Aims 
The goal of this project was to maintain high-quality care and comply with CMS 
guidelines and national and institutional standards by extending NP service coverage to support 
CIED management during an MRI. The specific aim of the DNP led evidence-based project was 
to improve MRI access for all patients with CIEDs through the policy and procedure revision, 
creation of standardized workflows, and extension of hours for MRI by October 7, 2019.  
Section III: Methods  
Context 
This quality improvement project promotes patient safety and throughput by providing 
access and the necessary care for all patients who have CIEDs and need MRIs.  The key 
stakeholders for this project include arrhythmia, neurology, and radiology leadership teams, 
medical directors, arrhythmia NPs; and neurology, and radiology staff.  All teams were aware of 
the need for change.  
CMS provided clear guidelines in the supervision of the CIED during an MRI.  To 
promote patient safety and align with best practices, it was necessary to support this 
endeavor.  Non-compliance with the recommended guidelines poses risks to patient safety and 
potential liability.  Per Wikman-Svahn and Lindblom (2018), the interpretation of risk magnifies 
ethical issues.  Providing NP CIED management during an MRI minimizes the potential patient 
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safety risk concerns.  The perspective of risks as probabilities and consequences is utilized in 
risk-benefit- analysis in healthcare organizations (Wikman-Svahn & Lindblom, 2018).  
After the findings from the AMC’s neurology retrospective, one-time chart review was 
brought to the arrhythmia and radiology teams, a collective decision involving all stakeholders 
was made to create a plan supporting the safe facilitation of MRIs for patients with CIEDs.  The 
neurology team utilized a patient data analytics tool to identify patients with the diagnosis of 
stroke, transient ischemic attack (TIA), or acute neurological symptoms and had a CIED.  Those 
patients were cross-referenced with a CIED database to determine the conditionality of their 
CIED.  The outcome demonstrated that approximately 2.5 patients per month did not receive 
MRIs since they had non-conditional CIEDs.  In January 2019, the radiology team requested a 
clinical and business analytics (CBA) report to identify all patients who needed MRIs and had 
CIEDs. The report demonstrated from January to October there were 350 conditional and non-
conditional CIED MRI requests, 33% were patients with neurological conditions. This data 
further validated the need for CIED management during an MRI.  
Adherence to the recommendations and staffing requirements of the 2018 CMS device 
management guidelines was necessary for reimbursement.  The arrhythmia team expressed 
concerns that they could not adhere to the CIED management guidelines since they did not have 
enough NPs to support device management for all patients with conditional and non-conditional 
CIEDs.   Although the MRI department has two suites that have the capacity to provide 1.5T 
magnetic strength, only one was being utilized for complex cardiac cases, thus impeding access.  
Extending weekly NP device management support for all CIEDs would enable imaging to 
accommodate three to four additional MRI cases per day (21-28 per week).  Additional NP FTEs 
were necessary to implement extended hours of service.  To reduce the direct cost of adding NPs 
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for the extended hours, the NPs would also assist in Catheterization Angiography Laboratory 
(Cath Lab) procedures and provide cardiovascular consultations throughout the hospital.  
Intervention 
The evidence-based change-of-practice project comprised of policy and procedure 
changes, standardization of workflows, maximizing equipment utilization and availability, 
modification of MRI scheduling, and implementation of required staffing support to manage the 
CIED during an MRI.  Policy and procedure revisions were necessary to allow NPs to practice 
within their scope.  Standardizing workflows for CIED MRI management was fundamental for 
consistent care.  The utilization of a second MRI suite and access to CIED programmers was 
necessary to increase service capabilities.  Creating a patient scheduling process was necessary to 
promote concise communication between the radiology and arrhythmia teams.  Developing a 
staffing model was mandatory to comply with CMS requirements.  
Study of the Intervention  
Gap analysis. A gap analysis was conducted to identify inconsistencies.  The MRI 
department had one dedicated day to schedule and perform one to two MRI studies for complex 
cardiology cases, which included patients with non-conditional CIEDs (see Appendix C).  Prior 
to the intervention, the arrhythmia NP team did not have a standardized workflow or a staffing 
model to provide consistent CIED supervision during an MRI.  The MRI department did not 
have the device management programmers conveniently stored in the department, creating an 
inefficient workflow for the arrhythmia team.  The arrhythmia team had to find the programmer 
in the clinic and transport it to the MRI department.  The MRI scheduling process specific to 
non-conditional CIEDs did not exist.  Prior to the intervention, the state of this service was 
inefficient and inconsistent, creating delays in patient care. 
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Gantt chart.  An action plan and timeline specific to this project are shown on the Gantt 
chart (see Appendix D).  This tool defined the path necessary for the completion of the 
improvement activity, provided a foundation for scheduling tasks, and was useful in managing 
the project’s activity schedule.  The initial stages of the project began in early January 2018, 
when the project was identified. Once the proposed project was approved by the DNP chair, 
tasks such as creating an AIM statement, identification of stakeholders, and confirming baseline 
metrics to support the need of this improvement project were determined.  The project plan, 
work breakdown structure, and the business plan were finalized in May 2018.  In the fall of 
2018, the business plan was presented in a situation, background, analysis or assessment, and 
recommendations (SBAR) format to our leadership teams and stakeholders (see Appendix E).  
The business plan was approved in January 2019.  The development of the electronic document 
workflow and a screening tool was finalized in January 2019 (see Appendix F).  In January 2019, 
the CIED MRI policy and procedure were finalized, and the NP staffing plan confirmed. 
Arrhythmia NP recruitment began in February, with three of the 4.5 NP FTEs hired by August 
2019 (see Appendix G).  The goal was to implement the extended NP coverage by early October 
2019.  During the fall and winter of 2019, the teams will continue to have touch point meetings 
to discuss any post-implementation issues with the new staffing model and conduct a plan, do, 
study, act (PDSA) to evaluate the intervention (see Appendix H).  A similar retrospective chart 
review utilizing the CBA report to collect data on patients who require an MRI and have a CIED 
will continue to be performed.  The DNP student will monitor, analyze, and evaluate the 
outcomes closely post-intervention to determine if the goal of having no patients turned away for 
an MRI is achieved.  Mitigation plans will be discussed, developed, implemented, and evaluated.  
Once data is received, the outcomes will be presented to the teams and stakeholders. 
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Work breakdown structure.  The work breakdown structure (WBS) for this project 
organized the deliverables into sections (see Appendix I).  It was used as a communication tool 
to supplement the Gantt chart.  It defined the scope of our project and allowed oversight of each 
task.  The WBS had a hierarchical composition of the range of the project.  There were three 
levels in this project’s WBS.   Planning and oversight involved developing the project plan, 
creating a project charter, and performing a gap analysis demonstrated in the four quadrant A3.  
The budget and business plan identified accountability, staffing needs, projected volumes, return 
on investment, and implementation costs.  Education was associated with performing literature 
reviews and educational sessions with staff.  Resources comprised of tasks such as reviewing 
HRS workflow recommendations and CMS staffing guidelines, comparing staffing and device 
management workflows from other organizations, and approval of the business plan.  The staff 
category included the recruitment and hiring of NPs, proposal of a staffing plan and schedule, 
onboarding of NPs, and vetting schedules with the team and stakeholders.  The implementation 
of intervention consisted of confirmation of NP extended hours’ schedule, workflow review, 
monitoring of intervention, performing PDSA cycles if needed, and comparing data pre- and 
post-intervention. 
Responsibility/Communication plan.  As one of the team leaders of this project, the 
DNP student maintained oversight of the project and reported the progress of the intervention 
during scheduled meetings and via email.  Maintaining accountability and communication was 
necessary to align with AMC’s current organizational process and structure.  The project 
improvement team included staff nurses, MRI technicians, NPs, department managers, medical 
directors, and department directors.  Reporting of this project’s findings and results to the team 
and stakeholders occurred after meetings and milestone completion (see Appendix J).  Post-
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implementation data reports were initiated on October 7, 2019 and will continue weekly for one 
month, monthly for three months, quarterly for one year, and then yearly thereafter. 
SWOT analysis.  The strengths, weaknesses, opportunities, and threats (SWOT) analysis 
(see Appendix K) enabled the DNP student to identify the challenges in meeting the specific 
project aim.  The strengths of this project included the improvement of patient throughput and 
access, patient satisfaction, promoting patient safety, compliance with CMS staffing guidelines, 
creation of an updated CIED MRI policy and procedure, development of electronic 
documentation workflows, and providing a revenue-generating service.  The only weakness 
identified was the MRI management support was only available for patients who presented with 
acute neurological conditions.  Opportunities included serving the non-neurological patients who 
need an MRI and have a non-conditional CIED, and creating an extended hours plan.  Threats 
included the rejection of 4.5 NP FTEs, business plan approval, and new hospital construction.     
Intervention budget. The five-year financial analysis for the intervention is shown as 
Appendix L. Labor costs include the type of procedures, such as those performed in the Cath Lab 
by the NPs during the extended hours of service, including the provision of device management 
support at the time of the MRI.  Also reviewed were non-labor costs, such as the amount of time 
spent by the staff, administrators, and the DNP student on planning this improvement project.  
Based on the financial analysis, 6.5 NPs are required to comply with CMS guidelines and 
support twenty-four hours, seven days per week, inpatient and outpatient cases. Two FTEs were 
previously approved for the new hospital activation in fall 2019; therefore, the net incremental 
request was for 4.5 NP FTEs.  The first year anticipated a net loss of $347,396 is due to salaries 
and benefits, not fully ramping up with the projected number of procedures, as well as the 
frequent interdisciplinary team meetings needed for planning. Years two through five projects an 
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average annual net gain of $201,525.  It was necessary to demonstrate a positive return on 
investment (ROI) to influence key stakeholders to support this quality improvement project.   
Measures 
The outcome measure was improved MRI access and throughput for patients with 
CIEDs, measured by all patients with CIEDs that have active MRI orders, ascertained through 
the CBA tool.  Those patients were manually cross-referenced with completed procedure notes in 
the electronic medical record. The arrhythmia and radiology teams captured this discrete data 
through an electronically-generated report.  
One process measure was the number of patients turned away from MRI due to a non-
conditional CIED, determined through the CIED database, and confirmed by arrhythmia NPs 
that the reason for exclusion was due their non-conditional CIED (see Appendix M).  A second 
process measure was the volume of all patients who have CIEDs and require an MRI. The 
AMC’s CBA report and the patient’s electronic medical record were the tools used to measure 
volume and determine the number of patients who were deferred an MRI.  Through the CBA 
report and electronic medical records, the arrhythmia and radiology teams will perform post-
implementation completion assessments weekly for one month, monthly for three months, 
quarterly for one year, and then yearly thereafter. 
Analysis 
In the initial assessment and planning of this quality improvement project, gaps in current 
practice were identified.  Pre-intervention data was collected by performing a retrospective chart 
review of all patients who presented with acute neurological conditions, had a CIED, and 
required an MRI.  Data was collected from the CBA report and the AMC’s data management 
application by using diagnosis codes and keywords and a retrospective electronic chart review.  
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Microsoft Excel was utilized to capture and compare the data pre- and post-intervention.  De-
identified data were extracted from patient medical records and included in the spreadsheet. The 
final analysis will include the post-implementation data extracted during the scheduled 
monitoring period.  
Ethical Considerations 
Nursing is based on the foundation of compassion and benevolence for the health and 
respect of patients, families, and communities (American Nurses Association [ANA], 2015). 
This project supports the ANA code of ethics to formulate and maintain a standard for nurses to 
utilize ethical analysis and decision-making. The implementation of extended NP staffing 
coverage to manage CIEDs during an MRI demonstrates accountability and responsibility for 
nursing practice.  
 This evidence-based improvement project embodies the Jesuit value of cura personalis, 
suggestive of individualizing the care and attention to the whole being (McGinn, 2015). The 
goals of this quality-improvement project were to promote patient safety, improve patient 
throughput and access, and maintain high standards of care. As a non-research project, it did not 
require Institutional Review Board (IRB) approval for implementation.  The project was 
evaluated and approved as a quality improvement endeavor through the University of San 
Francisco School of Nursing and Health Professionals (see Appendix N).   
Section IV: Results  
 Hiring and training 4.5 NP FTEs was critical for the implementation of extended hours of 
CIED management support during an MRI, 24 hours per day, seven days per week.  The 
arrhythmia team has successfully hired two NPs, both with limited cardiovascular health and 
CIED experience.  Training for the two NPs is expected to be completed between November 
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2019 and January 2020.  Recruitment continues for the remaining 2.5 NP FTEs.  Support will be 
provided by extending the hours of service every Monday and Tuesday from 7 am until 11 pm 
starting October 7, 2019.  Since implementation, the NP has supervised 18 MRIs after 5 pm.  
When all 4.5 NP FTEs are hired, the capacity to provide 24 hours per day, seven days per week 
accountability in CIED management during an MRI will have been achieved.  Based on the CBA 
report identifying the volumes of patients with CIEDs requiring an MRI (see Appendix O), it is 
imperative that active NP recruitment is continued to fill the necessary positions in order to fully 
implement this improvement project and maintain adherence to CMS staffing requirements.   
Section V: Discussion  
Summary 
The aim of the DNP led the evidence-based project in improving MRI access for all 
patients with CIEDs through the policy and procedure revision, creation of standardized 
workflows, and extension of hours for MRI was achieved.  Key findings include the neurology 
team’s retrospective chart review from 2017 that established the need for device management 
support for patients who present with acute neurological conditions, such as stroke and TIAs and 
have non-conditional CIEDs.  The findings determined that 2.5 patients per month did not 
receive an MRI due to their non-conditional CIEDs.  The review concluded that of the CIEDS, 
75% were pacemakers, made by one specific vendor.  We confirmed that patients with 
conditional CIEDs did not receive an MRI due to the misconception that the device was non-
conditional.  This data was concerning for the physician leaders from neurology, radiology, and 
arrhythmia teams and prompted an urgent need to find a solution to provide safe patient care (see 
Appendix P).   
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Stakeholder recognition of project implication on patient safety and interdisciplinary 
collaboration contributed most importantly to the successful changes.  Leadership support and 
fostering team spirit were essential in achieving favorable outcomes.  Integrating the best 
available evidence on quality of care, clinical outcomes, and patient satisfaction were necessary 
on the impact of advanced practice nursing.  The implementation of the NPs in the CIED MRI 
management improved patient outcomes, thus impacting the advanced practice nursing role.  
Interpretation 
The DNP project was guided by the published literature in combination with CMS 
requirements and clinical expertise.  The findings from the studies were consistent with some of 
the literature review and validated the safety of MRI for non-conditional CIEDs at low magnetic 
strength.  Implementation of the new CIED MRI workflows impacted patient throughput by 
providing safety guidelines for the non-conditional CIEDs.  The AMC now has the capacity to 
provide MRIs for all patients regardless of the conditionality of their CIED. 
Limitations 
 Since this is a non-research study, there are limitations to the generalizability of the 
results.  Barriers to implementation were concentrated in recruitment, hiring, and training of the 
NPs. The arrhythmia team faced challenges to recruit the approved 4.5 NP FTEs. The number of 
interested NPs interested who have cardiovascular health experience is extremely 
limited.  Hiring inexperienced NPs and providing the necessary training was the chosen 
alternative, although this strategy introduced additional challenges.  The onboarding process, 
which includes credentialing, can take three months for each NP.  Training inexperienced NPs 
could take up to nine months.  With each new, inexperienced NP, it will take approximately one 
year to gain the competency to work independently.  Considering these timelines, the arrhythmia 
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team was concerned it could take more than a year before full implementation of extended hours 
of service to 24 hours a day, seven days per week for CIED management can be achieved.  
Since the arrhythmia team could not hire all the necessary NPs to fully implement the 
project, expectations were adjusted.  Since March 2019, only three NPs were hired, two with 
minimal cardiac and CIED experience.  After credentialing, the two NPs with limited experience 
will be fully trained between November 2019 and January 2020.  Retention of NPs has also been 
challenging.  One NP who had CIED experience recently resigned. These obstacles will not 
change the goal of improving MRI access for patients with CIEDs, but rather adjust how the 
arrhythmia team will be providing this service until all the necessary staff have been hired and 
trained.     
Conclusions 
The CVH service line’s goal is to create a value-added framework for the CVH patient 
that spans the continuum of care by engaging teams in building a network of care programs thus 
improving access, capacity, quality, and patient experience.  This quality improvement project 
supported the AMC’s pillars of quality, service/patient experience, employee engagement, and 
financial strength.  By implementing a national staffing model for patients who require an MRI 
and have a CIED, the AMC has provided the appropriate care for these patients, minimizing 
patient safety concerns, and improving patient service and experience.  The collaborative effort 
between the arrhythmia, radiology, and neurology departments demonstrated meaningful 
development of a positive interdisciplinary working relationship. The arrhythmia NPs and 
radiology staff nurses view this project as a double benefit of adding value to patient care and 
streamlining workflows.  By implementing the CMS national staffing model for patients who 
require an MRI and have a CIED, the AMC has provided the appropriate care for these patients, 
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minimizing patient safety concerns, and improving patient service and experience.  Ensuring the 
sustainability of this project will require an ongoing commitment.   
Section VI: Other Information  
Funding 
There were no special funding sources affiliated with this evidence-based quality 
improvement project.  All resources and time associated with the investigation, development, 
implementation, and evaluation were included in the current pay structure and process. 
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SECTION VIII: APPENDICES 
Appendix A – Letter of Support from the Organization 
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Studies                                            
Author & Year
Russo et al. 
(2017)













& Padley, S. 
(2013)
Shenthar et al. 
(2015)
Shah et al. 
(2018)
Wilkoff et al. 
(2011)
Bailey et al. 
(2016)
Nazarian et al. 
(2017)
Van der Graaf, 
A.W.M., 




Ertl, G., & 
Ritter, O. 
(2015)
Thoracic 1.5Tesla X X X X
Spinal 1.5 Tesla X X X X
Non-thoracic 1.5 Tesla X X X X X X
Full body 1.5 Tesla X X X X
Utilization of CIED MRI Protocol X X X X X X X X X X X
MRI Conditional CIED X X X X X X X X X
MRI Non-conditional CIED X X X X X
CIED Reprogramming X X X X X X X X X X X
Single Vendor Specific X X X X
Multi-vendor Specific X X X X X
Low to No MRI Related 
Complications/Adverse Effects X X X X X X X X X X X
Types of Magnetic Resonance Imaging (MRI)
Type of Cardiovascular Implantable Electronic Device (CIED)
Outcomes
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Appendix D – Gantt Chart 
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IT/EPIC (EMR) confirmation of electronic workflows
Finalize policy and procedure 
Confirmation of MRI CIED workflow approval
Confirmation arrhythmia team staffing plan - NP coverage
NP recruitment and hiring
Summer 2019  
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Workflow and CIED management education to nurse practitioners, 
radiology RNs, radiology techicians, and physicians
New NP onboading and training
Implementation of NP extended hours coverage
Fall 2019
Coordinate Team Meetings - Arrhythmia/Radiology/Neurology
Monitor outcomes of NP extended hours MRI coverage for CIEDs 
Perform PDSA 
Evalutate outcome of staffing implementation
Present outcomes
20192018
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Cardiology CIED screening form for patients 
undergoing MRI 
 
Please fax completed form to MRI 
Scheduling (650) 723-6036 
Ordering Physician Name (please print): Date 
and Time: 
Patient Name:                                                                        MR # DOB: 
The patient should be evaluated and reviewed for the following: 
Device Name and Model____________ 
Lead(s) Model: Atrial:_________  RV:_________   LV:__________ 
Date of device implantation _________________________ 
Is this MRI conditional system:   yes: o          no: o 
 o   No abandoned leads or wires, lead extenders, or lead adapters are present (confirmed with CXR within 2 weeks) 
o No broken leads or leads with intermittent electrical contact as confirmed by lead impedance history 
o For patients who have multiple MR-Conditional devices, the MR labeling conditions for all implants are satisfied 
o Pace polarity parameters set to Bipolar  
o The device is operating normally and within the projected service life and/or pulse generator has sufficient battery, not at ERI or EOL 
o In patients whose device will be programmed to an asynchronous pacing mode when MRI scan mode is On: no diaphragmatic 
stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms  
o All Lead impedance values ≥ 200 ohms and ≤ 1500 ohms  
o For Medtronic ICDs: SureScan ICD system: pacing lead impedance value: >200 ohms and <3000 ohms 
o All Lead capture thresholds: <2V @0.4 msec in devices programmed to asynchronous pacing mode 
o In BiV devices LV lead pacing impedance of ≥ 200 ohms and ≤ 3000 ohms;  
o Defibrillation lead impedances between 20 and 200 ohms  
o For Boston Scientific: Patient does not have an elevated body temperature or compromised thermoregulation at the time of the scan 
 
Patient’s intrinsic rhythm is:______________ 
Patient is pacemaker-dependent: Yes o                 Noo  
Recommendation for MRI: 
Based on the information documented above patient can proceed to have MRI:  
Yes o                 Noo 
Name of the EP RN/CNS/NP completing the form:______________ 
Date: ___________  
______________________________________________________________________________________  
For patients with MRI non-conditional CIEDs: 
“Patient informed about the potential adverse interactions between the CIED and MRI that may include the inhibition of pacing, CIED warming, 
vibration, skin or soft tissue burns, asynchronous pacing, induction of atrial fibrillation, induction of ventricular fibrillation, switch mode 
malfunction, rapid atrial stimulation, rapid ventricular stimulation, and alteration in the CIED programming with potential damage to CIED circuit or 
system dislocation leading to potential CIED malfunction resulting in potentially life-threatening arrhythmias, heart block, and death” 
Provider Name______________________________	
Date_____________________  





 Cardiology Order Set for Pacemaker/ICD programing 
for MRI 
Please fax completed form to MRI 
Scheduling (650) 723-6036 
Ordering Physician Name (please print): Date 
and Time: 
Patient Name:                                                                        MR # DOB: 
Home Phone: Work/Cell Phone: 
All fields MUST be completed to clear patient for MRI.  Incomplete forms will be rejected and sent back. 
The Patient was reviewed for the following: 
 o   Device Name and Model_______________________________ Lead(s) Model__________________ 
 o   An MR Conditional pacing device has been implanted a minimum of 6 weeks in the left     
        or right pectoral region post the lead maturation period. Date of device implantation _________________________ 
 o   No abandoned leads or wires, lead extenders, or lead adapters are present 
o No broken leads or leads with intermittent electrical contact as confirmed by lead impedance history 
o For patients who have multiple MR-Conditional devices, the MR labeling conditions for all implants are satisfied 
o Pace polarity parameters set to Bipolar  
o The device is operating normally and within the projected service life and/or pulse generator has sufficient battery, not at ERI or EOL 
o No diaphragmatic stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms in patients whose device will be programmed to an 
asynchronous pacing mode when MRI scan mode is On 
o All Lead impedance value ≥ 200 ohms and ≤ 1500 ohms  
o For Medtronic ICDs : SureScan ICD system: pacing lead impedance value: >200 ohms and <3,000 
o All Lead capture thresholds: <2V @0.4 msec.  
o In BiV devices LV lead pacing impedance of ≥ 200 ohms and ≤ 3000 ohms;  
o Defibrillation lead impedances between 20 and 200 ohms  
o For Boston Scientific: Patient does not have an elevated body temperature or compromised thermoregulation at the time of the scan 
Patient can proceed to have MRI: Yes o                 Noo 
Cardiology orders for device programming: 
Prior to MRI: 
For MRI conditional Devices:  
Medtronic: SureScan mode ON o 
St Jude: Confirmed MRI Setting status and the programmed MRI Mode settings o 
Boston Scientific: MRI protection Mode ON o 
For non-MRI conditional devices:  
o Deactivate monitoring and tachyarrhythmia therapies  
o Deactivate magnet response, rate response, PVC response, noise response, ventricular sense response and conducted AF 
response 
 
Is the patient pacemaker dependent? 
                                     o Yes: Program to: DOO   oVOO                    Pacing Rate: _____bpm 
                                    o No: Program to: DDI   oVVI 
During MRI:  
oMonitor blood pressure, EKG, O2 and symptoms during MRI 
Post MRI: 
oRecheck sensing, impedance and pacing thresholds and compare with baseline 
o Restore original programming.  
oPost-scan program MRI scan mode to OFF.   
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CIED MRI Workflows (Inpatient/Outpatient/Urgent) 
MRI ordered by primary team.  MRI/
Radiology Department identifies 







· Follow up in Device Clinic 3-6 months after MRI.
· Follow up in 1 week if any capture threshold increase >1.0V, 
sensing dropped >50%, pacing impedance changed >50% or 
shock impedance changed >5 ohms
Determine conditionality of CIED by 
Radiology staff in consultation with 
manufacturer
· MRI dept arranges for EP team 
or Device Rep to manage the 
CIED based on conditionality
· Device Rep will be notified to 
manage  the conditional CIED
· EP team will be notified by  MRI 
department to reprogram non-
conditional CIED or if Device Rep 
is not available for the study 8am 
-5pm
IP unit to fax 




· Include all CIED system other 
than those that meet MRI 
conditional labeling and all 
specified conditions of use
· No abandoned leads/wires/lead 
extenders/lead adapters (Xray 
may be required)
MRI Conditional CIED
· Any device for which a specified MRI 
environment with specified conditions of 
use does not pose a known hazard as 
confirmed by manufacturer.
· System beyond the exempt period for 
conditionality from the time of implant?  
· Device Implanted minimum of 6 weeks
· No abandoned leads/wires/lead extenders/
lead adapters (Xray may be required
MRI department faxes 
cardiology checklist/MRI 
clearance form to inpatient unit 
and instructs to page EP team 
at #15590 
· EP team evaluates patient’s device, 
determines dependency, and completes the 
MRI/Cardiology checklist/MRI clearance form
· EP team deems if pt is cleared for MRI
· Ordering provider contacts Dr. Wintermark or 
designee to discuss the risk/benefit of MRI for 
the pt.
· Ordering provider agrees to proceed with MRI 





Pt not cleared for MRI Pt cleared for MRI
Patient arrives 







· MRI staff to provide continuous ECG & pulse oximetry 
monitoring from 7am-5pm M-F
· EP team to provide continuous device monitoring 
pacemaker dependent patients
· Defib/monitor with external pacing function and 
programmer available in patient holding area and any 
resuscitative efforts that involve MR unsafe equipment 
would be performed after moving the patient outside zone 4 
· MRI personnel with skills to perform  ACLS in attendance 
during the time the patient is reprogrammed and until 
assessed and declared stable to return to unmonitored 
status.
Device Rep/EP 
team  to 
perform CIED 
evaluation 
post MRI and 
return to pre-
study settings
· Device Rep/EP team  to send 
interrogation report to EP team 
· If EP team not present, MRI staff 
in charge of the patient will 
document the Device Rep’s 
presence and assure completion 




in Paceart and 
EPIC
EP team uses 
smartphrase in 
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MRI/Radiology Department identifies 







Determine conditionality of CIED by 
Radiology staff in consultation with 
manufacturer
MRI Non-conditional CIED
· Include all CIED system other 
than those that meet MRI 
conditional labeling and all 
specified conditions of use
· No abandoned leads/wires/lead 
extenders/lead adapters (Xray 
may be required)
MRI Conditional CIED
· Any device for which a specified MRI 
environment with specified conditions of 
use does not pose a known hazard as 
confirmed by manufacturer.
· System beyond the exempt period for 
conditionality from the time of implant?  
· Device Implanted minimum of 6 weeks
· No abandoned leads/wires/lead extenders/
lead adapters (Xray may be required
Device Coordinator to 
notify patient and 
schedule for in-person 










completed by EP team 
and scanned to HMIS
The MRI dept arranges for 
Device Rep to re-program 
the device on day of study
Patient arrives 
in MRI for 
scheduled  
appointment
· Device Rep interrogates CIED
· If Device Rep not available at 
the time of the study, 
reschedule MRI
Device interrogation 
request sent to “CV 
Med Device Team” 
pool by MRI Dept: 







· MRI staff in charge of the patient will 
document the Device Rep’s presence 
and assure completion of the post-MRI 
form and scan pre/post device 
interrogation form into EPIC or complete 
EPIC dotphrase
· MRI staff will instruct patient to follow 
up in Device Clinic per Device Rep’s 
recommendations
Interrogation Encounter will be 
available for viewing in the 
“Procedure Tab” in EPIC
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MRI/Radiology Department identifies 





to patient’s RN and 
instructs to page EP 
team at #15590 
Patient arrives in 
MRI for MRI scan












· MRI staff to provide continuous ECG & pulse 
oximetry monitoring from 7am-5pm M-F
· Defib/monitor with external pacing function and 
programmer available in patient holding area 
and any resuscitative efforts that involve MR 
unsafe equipment would be performed after 
moving the patient outside zone 4 
· MRI personnel/EP team with skills to perform  
ACLS in attendance during the time the patient 
is reprogrammed and until assessed and 
declared stable to return to unmonitored status.
· Device Rep/EP team  will program 
device to non-pacing mode (OVO/
ODO) or inhibited  mode VVI/DDI 
with deactivation of advanced or 
adaptive features; 
· If CRT reasonable to program to 
asynchronous pacing with rate to 
avoid competitive pacing.  
· If ICD, deactivate tachycardia 
detection and therapies
Interrogation 
Encounter will be 
available for viewing 
in the “Procedure 
Tab” in EPIC
· Follow up in Device Clinic 3-6 months after MRI.
· Follow up in 1 week if any capture threshold increase >1.0V, 
sensing dropped >50%, pacing impedance changed >50% or 
shock impedance changed >5 ohms
RN pages EP team 
#15590
Device Rep/EP team  
to send 
interrogation report 
to Device RN 
Device Rep/EP team  
to perform CIED 
evaluation post MRI 
and return to pre-
study settings
· Is system beyond the exempt 
period for conditionality from 
the time of implant?  
· Device Implanted minimum of 6 
weeks
· No abandoned leads/wires/lead 
extenders/lead adapters (Xray 
may be required)
EP team evaluates 
patient’s device and 
completes the MRI/




Device Rep to 
re-program the 
device on day 
of study
Is device Rep 
available?
Device Rep will 
reprogram device
EP team will be 






RN to fax form 
back to MRI 
department
Yes
Device RNs uses 
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Appendix G – EP Nurse Practitioner Job Description 
ELECTROPHYSIOLOGY NP JOB DESCRIPTION 
Our fast-growing Cardiology EP department is currently seeking a Nurse Practitioner or Physician 
Assistant to join its prestigious team. The overall responsibility of this EP NP/PA is to provide high-
quality care to the arrhythmia patients under the supervision of the EP attending. 
SUMMARY: 
Primary responsibility of this position is to support inpatient hospital services including electrophysiology 
patient admissions, rounding, discharges, and EP coverage including admissions, education, discharge 
process, and discharge when needed, peri-operative management of patents undergoing EP procedures, 
evaluation and management of patients with cardiac arrhythmias, pacemakers, CRT-D, and defibrillators, 
and their devices, management of patients with CIEDs during MRI, engage in a consultative care of 
hospitalized patients and to collaborate with physicians, fellow, residents, and medical /APP students, 
assisting EP MD during device implant procedures and ablation procedures.  This position requires 
excellent communication skills and the ability to multi-task. Must have a professional, efficient, and 
caring attitude and be a cooperative team member, while maintaining and endorsing high clinical 
standards in both the outpatient and inpatient settings. 
ESSENTIAL DUTIES AND RESPONSIBILITIES: 
➢ Performs evaluation and problem identification of patients. 
➢ Performs history and physical examination of patients. 
➢ Consents patients for electrophysiology procedures. 
➢ Writes orders and interprets laboratory data and radiological tests. 
➢ Monitors patient status and response to treatments. 
➢ Documents findings in the medical record. 
➢ Recommends and orders appropriate therapeutic interventions and writes prescriptions for 
recommended pharmacologic treatments. 
➢ Interacts with consultants as appropriate. 
➢ Directs patient and/or family to agencies dealing with specific illnesses/diseases. 
➢ Participates in departmental quality assurance, risk management, and compliance efforts. 
➢ Discharges patients who require an overnight observation period after electrophysiological device 
placements or ablations. 
➢ Venous and arterial sheath removal 
ELECTROPHYSIOLOGY NP JOB DESCRIPTION: 
➢ Participates in daily team rounding, periodic M&M sessions and department conferences/teaching 
opportunities. 
➢ Perform ICD/PPM interrogations and programming during these clinics and as needed on inpatients. 
➢ Perform patient education during clinic for the patients and families of the aforementioned Physicians. 
➢ Make appropriate referrals. 
➢ Identify patients for research protocols and notify the PI and research coordinator of potential subjects. 
EDUCATION: 
A master’s degree in nursing and completion of an approved course of study as a nurse practitioner. 
Current ANCC certification and CA licensure as an NP is necessary. 
PREFERRED: 
Two years of Cardiology experience  
One year critical care experience  
Cardiac experience as an NP Computer Proficiency 
Employment Type: Full-Time 
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implementation of MRI 
CIED workflows.
1. Create backup 
staffing plan.
2. Observe 




1. Confirm patient data 
and identify gap(s).
1. Monitor patients 
turned away for MRIs
2. Implement new 
staffing plan.
2. Identify patients 
with CIEDs
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Appendix J – Responsibility/Communication Matrix 
 
Project Charter 
Project Name Expand MRI Access for Patients with CIEDs 
Problem Statement Arrhythmia Service would like to partner with the Radiology and Neurology Services to improve MRI access for patients with CIEDs. 
Project Scope 
Create standardized workflows for conditional and non-conditional CIEDs. 
Create business plan to support the CMS staffing standards for CIED management during MRIs. 
Obtain physician support to implement the standardized workflows. 
Create policy and procedure for MRI CIED management 
Metrics 
# Description   Target Current Accountability 
1 
Identify patients who presented with 
acute neurological conditions who 
have non-conditional CIEDs. 
  0% 2.5/month  
Neuro team 
2 
Create standardized workflows for 
conditional and non-conditional 
CIEDs. 
  100% 100% 
Rose G/Angela T 
3 
Create business plan to support the 
CMS staffing standards for CIED 
management during MRIs. 
  100% 90% 
Rose G/Angela T 
4 
Create policy and procedure for MRI 
CIED management 
  100% 80% 
Rose G/Angela T 
Project Benefits 
Improved staff engagement   
Improved health outcomes   
Improved transitions of care  
Improved patient satisfaction   
   
   
   
    
Team Members 
Sponsor(s), Team Leader, Performance 
Excellence Lead 
Team Members: 
Team Sponsors: S.S.; S.W.; C.K.; D.K.; 
P.W.; M.W. 
A.T.   
Team Leader: Rose Geronimo T.N.  
 
  R.R.   
Potential Barriers/Risks 
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Appendix K – SWOT Analysis 
Expanding Access to Magnetic Resonance Imaging for Patients with 




Improve patient throughput Creation of policy and procedure 
Improve patient satisfaction 
Development of staffing plan to improve patient 
flow 
NPs will provide evaluation of appropriateness of the 
MRI procedure 
NPs will provide device management for patients 
with CIEDs undergoing an MRI 
Promote patient safety Compliance with CMS guidelines 
Revenue generating 
Development of electronic documentation 
workflows 
Weaknesses   
Serving only neurological patients   
    
    
    
Opportunities   
Expand service for all patients with CIEDs Creation of extended hours plan versus 24 
hours/7 days per week coverage plan 
    
    
Threats   
Nurse Practitioner FTE approval Organization competing priorities (i.e.: new 
hospital construction) 
Budget approval   
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Appendix L – Budget/Financial Analysis 
 
Nurse Practitioner Procedures Year 1 Year 2 Year 3 Year 4 Year 5
Phase 1
Cardioversion (8/week) Ramp Up
Target Volume at Full Ramp Up = 416 208 416 416 416 416
Charge $2,031,083 $4,346,517 $4,650,773 $4,976,327 $5,324,670
Net Revenue (19% reiumbursement) $430,134 $886,076 $912,658 $940,038 $968,239
Direct Cost (Including salaries and benefits) $318,600 $443,833 $463,995 $485,103 $507,205
Contribution Margin $111,534 $442,243 $448,663 $454,935 $461,034
Operating Margin $89,039 $395,903 $400,933 $405,772 $410,397
MRI (22 conditional & non-conditional/week)
Target Volume at Full Ramp Up = 1144 572 1144 1144 1144 1144
Charge $9,758,978 $20,884,212 $22,346,107 $23,910,335 $25,584,058
Net Revenue (19% reiumbursement) $2,066,714 $4,257,432 $4,385,155 $4,516,709 $4,652,210
Direct Cost (Including salaries and benefits) $2,031,104 $3,456,229 $3,591,150 $3,731,680 $3,878,066
Contribution Margin $35,611 $801,202 $794,004 $785,029 $774,145
Operating Margin ($423,934) ($145,460) ($181,058) ($219,285) ($260,299)
Total Operating Margin ($334,896) $250,442 $219,875 $186,487 $150,098
Total Incremental FTEs 6 8 8 8 8
Cost of Meetings
Executive Leaders - VPs and Executive Directors (2 VPs/2 ED/4 qaurterly meetings) = $200/hr $3,200 0 0 0 0
Physician Leaders (3 MDs/6 meetings) = $250/hr $4,500 0 0 0
Managers/Nurse  Practitioners (3 Managers/1 NP/12 meetings for 1st year; 2 meetings 2nd 
year) = $100/hr $4,800 $800 0 0 0
Equipment - CIED Programmers (2) - Provided by vendor 0 0 0 0 0
Net Gain (Loss) ($347,396) $249,642 $219,875 $186,487 $150,098
Phase 2
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Appendix N – Statement of Non-Research Determination Form 
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Appendix O – Clinical Business Analytics Report – CIED MRI Volumes 
 
2019 ALL CIED MRI VOLUMES  
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Appendix P – Neurology Study 
 
 
 
 
 
 
 
 
 
 
 
